Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells

Arterioscler Thromb. 1994 Mar;14(3):438-42. doi: 10.1161/01.atv.14.3.438.

Abstract

We studied the effect of lipoprotein(a) [Lp(a)], low-density lipoprotein (LDL), and high-density lipoprotein (HDL) on tissue plasminogen activator (TPA) secretion from human endothelial cells. At 1 mumol/L, Lp(a) inhibited constitutive TPA secretion by 50% and phorbol myristate acetate- and histamine-enhanced TPA secretion by 40%. LDL and HDL also depressed TPA secretion by 45% and 35% (constitutive) and 40% to 60% (stimulated). TPA mRNA levels were also examined and found to change in parallel with antigen secretion. In contrast to TPA, plasminogen activator inhibitor type-1 secretion and mRNA levels were not affected by any of the three lipoproteins. These results suggest that the interaction of lipoproteins with certain cell-surface binding sites may interfere with the proper production and/or secretion of TPA.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cells, Cultured
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / metabolism*
  • Humans
  • Lipoprotein(a) / pharmacology
  • Lipoproteins / pharmacology*
  • Lipoproteins, HDL / pharmacology
  • Lipoproteins, LDL / pharmacology
  • Plasminogen Activator Inhibitor 1 / blood
  • RNA, Messenger / analysis
  • Tissue Plasminogen Activator / genetics
  • Tissue Plasminogen Activator / metabolism*

Substances

  • Lipoprotein(a)
  • Lipoproteins
  • Lipoproteins, HDL
  • Lipoproteins, LDL
  • Plasminogen Activator Inhibitor 1
  • RNA, Messenger
  • Tissue Plasminogen Activator